<DOC>
	<DOC>NCT02192996</DOC>
	<brief_summary>This pilot trial is designed to investigate the benefits of the use of probiotics in GUT microbiota development and/or immunological biomarkers and how this can be related with the clinical status of very low birth weight preterms during their first weeks of life at the neonatal intensive care unit(NICU).</brief_summary>
	<brief_title>Probiotic Supplementation to Improve the GUT Microbiota of Very Low Birth Weight Preterm, a Pilot Study</brief_title>
	<detailed_description>This pilot trial is designed to investigate the benefits of the use of mixtures of probiotics isolated from human milk in GUT microbiota development and/or immunological biomarkers. Furthermore, the relationship between evaluated parameters and the clinical status of very low birth weight preterms during their first weeks of life at the NICU will be analysed.</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<criteria>preterm infants with birth weight less than one thousand and three hundred grammes preterm infants with gestational age less than 29 weeks mayor malformations chromosomopathies congenital infections non parental consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Week</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>VLBW preterm</keyword>
	<keyword>GUT microbiota</keyword>
	<keyword>probiotics supplementation</keyword>
	<keyword>immune compounds</keyword>
</DOC>